Shares of Vitalhub Corp. (TSE:VHI – Get Free Report) have received a consensus rating of “Buy” from the five brokerages that are presently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among analysts that have covered the stock in the last year is C$10.05.
Several analysts have recently weighed in on the stock. Cormark raised their price objective on shares of Vitalhub from C$9.50 to C$10.50 and gave the stock a “buy” rating in a report on Wednesday, October 2nd. Canaccord Genuity Group boosted their price objective on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a report on Thursday, January 16th. TD Securities upgraded shares of Vitalhub to a “strong-buy” rating in a report on Monday, November 25th. Finally, Scotiabank set a C$14.00 target price on Vitalhub and gave the stock an “outperform” rating in a report on Thursday.
Read Our Latest Analysis on VHI
Vitalhub Price Performance
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Read More
- Five stocks we like better than Vitalhub
- Stock Splits, Do They Really Impact Investors?
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
- Consumer Discretionary Stocks Explained
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
- 3 Warren Buffett Stocks to Buy Now
- ASML: Strengths and Upside Remain Despite DeepSeek Worries
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.